New diagnostics, technology top agenda at Twin Cities Ocular Surface Disease Symposium
Click Here to Manage Email Alerts
The Twin Cities Ocular Surface Disease Symposium, Oct. 21-22 in Minneapolis, will include 12 hours of COPE continuing education credit and feature hands-on workshops with key devices and the latest in ocular surface disease technology.
“Ocular surface disease (OSD) is one of the leading causes of patient dissatisfaction and visual quality issues in modern eye care practices,” Ahmad Fahmy, OD, the symposium’s program chair, said in an event press release. “Diagnostic and treatment technologies, and their applications to address OSD, are developing so quickly that a comprehensive meeting like this is particularly valuable.”
According to the release, data from the 2023 Optometric Trends Discovery Group survey of nearly 300 optometrists revealed that 77% of optometrists are not implementing a dry eye questionnaire, 45% lack access to meibography, and 30% do not believe cataract surgery should be delayed if there is significant ocular surface disease.
The survey also found that, on average, respondents believe 64% of dry eye patients have meibomian gland dysfunction, 4.4% of their patients have neurotrophic keratitis, and 4.5% of their patients have thyroid eye disease. These topics are among key discussion points at this year’s meeting.
“In addition to core OSD topics, we will also cover innovations [such as] the limbal stem cell regenerative approaches and practical topics including how to talk to your patients, implementing in-office treatments and the importance of nutrition,” Fahmy said in the release.
The program, which will also include industry panel discussions and best practices in eye care, is open to optometrists, ophthalmologists, technicians and administrators.
Collapse
Press Release
Read more about
Click Here to Manage Email Alerts